weltevree schreef op 14 november 2016 14:22:
?Conclusions
• rhC1INH 50 IU/kg (up to 4200 IU/kg) administered once or twice weekly significantly reduced the number of HAE attacks
– Most patients had =50% reduction during treatment with rhC1INH
– 22 of 23 patients (95.7%) had =50% reduction with twice weekly rhC1INH
• Administration of rhC1INH for up to 8 weeks was generally well tolerated
• Further research on rhC1INH as prophylaxis for the prevention of HAE attacks is warranted